GlassScriptPhysician profile
Justen J Sumner
NPI 1629496294
$4,017.73
in general payments reported to CMS, 2019-2025
29 companies · $672 in 2025
The $672 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $123 · 2021: $670 · 2022: $961 · 2023: $727 · 2024: $584 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,908 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.75 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,108.36 | 2019-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $425.70 | 2022-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $418.80 | 2019-2025 | Injectafer |
| Sumitomo Pharma America, INC. | $325.90 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $263.56 | 2021-2022 | |
| Myriad Women'S Health, INC. | $130.60 | 2023 | Myrisk |
| Exeltis, USA INC. | $128.57 | 2023-2025 | Slynd |
| Pfizer INC. | $124.09 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.90 | 2019-2025 | |
| Evofem Biosciences, INC. | $121.50 | 2021-2025 | Solosec, Phexx, Phexxi |
| Mylan Pharmaceuticals INC. | $90.60 | 2021-2022 | |
| Sage Therapeutics, LLC | $84.48 | 2025 | Zurzuvae |
| Terumo Medical Corporation | $76.56 | 2021 | |
| Aspira Women'S Health INC | $73.02 | 2020-2024 | Ova1 |
| Hologic Sales and Service, LLC | $65.90 | 2023-2025 | Aptima, Thinprep 2000 Processor |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $64.93 | 2021-2025 | Paragard T 380a |
| Therapeuticsmd, INC. | $57.18 | 2022 | |
| Mayne Pharma Commercial LLC | $56.13 | 2022-2025 | |
| Meditrina | $55.51 | 2021-2025 | |
| Conmed Corporation | $37.64 | 2024-2025 | Airseal |
| Davol INC. | $30.61 | 2021 | |
| Exact Sciences Corporation | $29.59 | 2024 | Cologuard Collection Kit |
| Organon LLC | $25.98 | 2023 | Nexplanon |
| Teleflex LLC | $21.99 | 2025 | Quikclot |
| Renovia INC | $20.13 | 2021 | |
| Urovant Sciences INC | $17.70 | 2022 | |
| Olympus America INC. | $16.85 | 2023 | Olympus |
| Agile Therapeutics, INC. | $12.69 | 2022 | |
| Merck Sharp & Dohme LLC | $11.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justen Sumner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.